Besides, FABP5 promotes lymphatic metastasis in cervical cancer, prostate cancer progression, breast cancer progression, and KC differentiation by reprogramming fatty acid metabolism through the NF-κB signaling pathway [52, 58, 59]. Here, NFKB1 is linked to breast carcinoma.